Several aldolase B clones from a human liver cDNA library have been identified by using a rabbit aldolase A cDNA as a hybridization probe. The most complete of these, pHL413, is 1389 base pairs long and covers -80% of the length of the mRNA, including 90% of the translated region. The cDNA, pHL413, was used to identify a genomic clone, XHG313, which encoded the remaining amino acids of human aldolase B. We demonstrate that the amino acid and nucleotide sequences of aldolase are strongly conserved even between different isozymes. Furthermore, in the 3'-untranslated regions of the mRNAs for the B isozyme of human and rat there is an extensive stretch of homology. Aldolase B lacks a cysteine at positions 72 and 338 and lacks a histidine at position 361. These residues, which are present in rabbit aldolase A, have previously been proposed to take part in catalysis. Our findings suggest that this may not be the case.
Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) is a glycolytic enzyme that catalyzes the reversible conversion of fructose 1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. The enzyme consists of a tetramer of identical 40,000-dalton subunits. In vertebrates, three isozyme forms exist. These can be distinguished by their electrophoretic and catalytic properties (1) . The amino acid sequence of the region around the active site lysine has been determined for aldolases from several sources (2) (3) (4) (5) (6) (7) (8) . The similarities among these sequences suggest that the amino acid sequence of aldolase is greatly conserved throughout vertebrate evolution. The differences show that they are indeed distinct proteins, the products of a family of related genes. The study of the genes for this enzyme is of interest because the expression of isozyme forms is regulated during development and because they represent a poorly characterized class of genes, the so-called "housekeeping genes," which are expressed in all cells.
Mammalian tissues express the aldolase isozymes in a well-characterized pattern (9) . The developing embryo produces aldolase A, which continues to be expressed in many tissues of the adult. In some tissues-for example, muscleadult expression of aldolase A is dramatically increased over that of the embryo. Here it may represent as much as 5% of total cellular protein (10) . In adult liver, kidney, and intestine, aldolase A expression is repressed, and the aldolase B isozyme is produced. In brain and nervous tissue, aldolase A and the third isozyme, aldolase C, are coordinately expressed in roughly equal quantities. Additionally, in some types of cells aldolase expression may be stimulated by insulin (11) or steroids (12) . These examples show that control of aldolase expression takes several forms. Investigation of aldolase expression may provide insights into a variety of mechanisms of gene regulation.
The study of the expression of aldolase B is of particular interest. Regulation of the aldolase genes is altered in hepatoma cells (13, 14) . In transformed liver cells production of the adult isozyme, B, is shut off and the embryonic form, aldolase A, is produced again. Furthermore, in humans deficiencies of aldolase B result in a genetic disorder, hereditary fructose intolerance (15, 16) . Determination of the nature of the defect(s) that cause hereditary fructose intolerance at the genetic level and investigation of the regulation of the gene during development and oncogenesis require nucleic acid probes specific for aldolase B.
This paper describes the isolation and characterization of several cDNA clones for human aldolase B. From the nucleotide sequence of the cDNAs and a genomic clone, we deduce the entire amino acid sequence for this previously uncharacterized protein. This information allows us to confirm the existence of a high degree of homology between the aldolase isozymes throughout their sequences. The derived amino acid sequence contains information relevant to a mechanism of catalysis that has been proposed for aldolase.
MATERIALS AND METHODS
Materials. Poly(G) was from Collaborative Research. 32p-labeled nucleotides were from Amersham. The Klenow fragment of Escherichia coli DNA polymerase I came from New England Nuclear. The primer for sequence analysis reactions was prepared by Chiron (Emeryville, CA). Nitrocellulose filters were purchased from Schleicher & Schuell.
BamHI, EcoRI, Pst I, T4 DNA ligase, and E. coli DNA polymerase were from New England BioLabs.
Human Liver cDNA Library. The human liver cDNA library was generously supplied by R. Hallewell (Chiron) in the form of supercoiled recombinant plasmid. The vector used was a derivative of pBR322. Double-stranded cDNA was prepared from poly(A)+ RNA from human adult liver according to the method of Villa-Kamaroff et al. (17) and was inserted into the Pst I site of this plasmid by oligo(dGdC) tailing (R. Hallewell, personal communication).
Screening of the cDNA Library by Colony Hybridization. E. coli strain MM294 was transformed with supercoiled DNA from the plasmid library (18) . Colonies were grown on nitrocellulose filters ('1000 colonies per filter) and screened according to the procedure of Grunstein and Hogness (19) by using a rabbit aldolase A cDNA as a hybridization probe.
The cDNA probe encoded the 3' two-thirds of the rabbit aldolase A mRNA (20) . The cDNA insert was excised by restriction endonuclease digestion using Pst I, gel purified, and 32P-labeled to a specific activity of 5 x 107 cpm/pug by nicktranslation (21 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. ml at 55TC for 3 hr. The filters were then placed in a fresh sample of the same solution, to which denatured hybridization probe had been added. The concentration of probe was 4 x 105 cpm/ml and 2 ml was used per filter. Hybridization was permitted to take place at 550C for 16 hr. The filters were washed repeatedly in 0.30 M NaCl/0.03 M sodium citrate, pH 7.0, at 450C, and then exposed to film. Filters were also probed by using a human aldolase B cDNA, pHL216. When using this probe, the same procedures were followed, except that prehybridization, hybridization, and washes were done at 680C.
Purification of Plasmid DNA. Selected bacterial clones were grown to OD550 = 0.6 and then further incubated for 20 hr in the presence of 60 ,tg of chloramphenicol per ml. The DNA was then harvested by the lysozyme/NaDodSO4 lysis method described by Godson and Vapnek (22) Purification of Phage DNA. A 500-ml culture of E. coli strain BHB2600 at OD550 = 0.50 was inoculated with 1012 plaque-forming units of XHG313. When the bacteria lysed, the phage were collected by precipitation with polyethylene glycol and purified by centrifugation on discontinuous CsCl gradients (24) . The DNA was released from the phage particles by treatment with formamide and was precipitated with ethanol.
Purification of Poly(A)+ RNA. HeLa cells were homogenized in 6 M guanidine thiocyanate, and the RNA was purified by centrifugation through 5.7 M CsCl (25) . Poly(A)+ RNA was selected by fractionation on an oligo(dT)-cellulose column (26) . Poly(A)' RNA from adult human liver tissue was a gift from R. Hallewell.
Blot Hybridization of RNA. Poly(A)+ RNA was denatured with formaldehyde and electrophoresed on 1.0% agarose gels containing 6% formaldehyde and 20 mM potassium phosphate at pH 7.0. The RNA was transferred to nitrocellulose filters (27) and probed with nick-translated plasmid pHL413 in a buffer of 50% deionized formamide/0.75 M NaCl/0.075 M sodium citrate/10 mM Hepes, pH 7.0/200 ,ug of sonicated calf thymus DNA per ml/1 x concentrated Denhardt's solution. For stringent hybridization, the filters were incubated in this buffer at 55°C and washed in 0.30 M NaCl/0.03 M sodium citrate, pH 7.0, at 65°C. Nonstringent hybridization took place at 37°C, and the filters were washed with 0.03 M NaCl/0.03 M sodium citrate, pH 7.0, at 55°C.
Sequence Analysis. The cDNA inserts were excised from the plasmids by restriction endonuclease digestion using Pst I, according to the procedure recommended by the manufacturer. The inserts or their fragments were gel purified and subcloned into the bacteriophage vector M13mp8 at the Pst I site (28) . Similarly, two 3.4-kilobase EcoRI-BamHI fragments were purified from a digestion of XHG313 and ligated into EcoRI-, BamHI-digested M13mp8. Sequence analysis was performed by the dideoxy technique of Sanger et al. (29) with a commercially prepared oligonucleotide complementary to M13mp8 as a primer for the Klenow fragment of E.
coli DNA polymerase I.
Computer Analysis. DNA and protein sequences were analyzed by using the programs of H. Martinez with the University of California, Berkeley, VAX/UNIX system.
RESULTS
A number of cDNA clones were selected from 4 x 104 human liver cDNA transformants in two separate screenings.
A rabbit aldolase A cDNA and later one of the human liver cDNAs were used as hybridization probes. The largest of the clones isolated, pHL413, was used to hybridize to various RNAs (Fig. 1) . Under stringent, conditions pHL413 hybridized to a 1700 + 25-nucleotide kNA from human liver but failed to hybridize to RNA fromn HeLa cells that produce aldolase A (30) . Under low stringency a rabbit aldolase A cDNA will hybridize to this HeLa RNA showing a 1725 ± 25-nucleotide mRNA for aldolase A. We conclude that pHL413 and the other overlapping clones encode the human aldolase B mRNA and not aldolase A, which is found in liver as -=5% of the total aldolase (9) .
The cDNA inserts of four partially overlapping clones were subcloned into the Pst I site of the bacteriophage vector M13mp8 and subjected to sequence analysis. The clones showed homology to the rabbit aldolase A cDNA used for a probe and corresponded to the coding region from amino acid 34 to the carboxyl terminus of the protein, with an additional 395 nucleotides of the 3'-untranslated region. Fig. 2 shows how three of these clones, pHL413, pHL216, and pHL201, correspond to the full-length message. The two clones pHL216 and pHL201 overlapped each other by 8 base pairs (bp) and both overlapped the 1389-bp pHL413 clone.
To determine the first 33 amino acids, it was necessary to sequence a genomic clone of human aldolase B. Costanza et al. have sequenced a 111-bp human aldolase B cDNA, R38, which predicts a BamHI site at the codons for amino acids 28 and 29 (31) . The regions adjacent to the unique BamHI site of the insert of XHG313 were subjected to sequence analysis. Fig. 3 shows the overlap of this genomic DNA sequence with other human aldolase B DNA sequences. The sequences of XHG313 and pHL413 overlapped by only 12 bp. This was due to the existence of an intervening sequence that interrupts the coding region of the gene at amino acid 37 (unpublished data). However, the clone R38 (30) bridges this junction (Fig. 3) . The excellent agreement between the nucleotide sequences of XHG313, R38, and pHL413 suggests that they all correspond to the same protein. Three discrepancies were found. These can be attributed to allelic differences or errors in sequence analysis. The high degree of overlapping sequence indicated that this fragment of genomic DNA was from the human aldolase B gene where the codons for the first 37 amino acids were encoded.
The amino acid sequence for human liver aldolase derived from these clones can be compared to the known partial amino acid sequences of aldolases from other sources. The tryptic peptide containing the active site lysine (position 229) has been sequenced for several aldolases (2-8). In Fig. 4 , the aldolase B amino acid sequences from ox, rat, rabbit, and human are compared to the same peptide of aldolases A and C. The aldolase B isozymes have amino acid residues in common that distinguish them from aldolases A and C. At The sequence analysis strategy is described at the bottom. The horizontal arrows indicate the direction of sequence analysis from the internal and flanking Pst I sites. Each arrow represents a sequence that was determined in two independent trials. Forty percent of the DNA was subjected to sequence analysis in both directions. position 217, the B isozymes have an asparagine where A and C have a serine, and at position 241 there is a lysine where A and C have a glutamic acid or glutamine residue. The derived sequence of the cloned human aldolase was identical to the ox and rabbit aldolase B in this region, suggesting that the clones correspond to the B isozyme.
The sequence reported here along with the protein translation is summarized in Fig. 5 . This sequence corresponds to the entire amino acid sequence of aldolase B and 88% of the length of the mRNA. The structure of the message is not known precisely. Assuming that the poly(A) tail is 100 nucleotides long, there remain -100 nucleotides in the 5'-and 3'-untranslated regions of the message that are yet to be determined. DISCUSSION Tsutsumi et al. (8) have published a 1200-nucleotide cDNA clone of rat aldolase B, which corresponded to the mRNA from the codon for amino acid 184 through to the poly(A) tail. Comparison of the sequences of the rat and human aldolase cDNA clones showed that they share an overall nucleotide homology of 88% in the coding region. The amino acid sequences derived from the DNA sequences are 94% homologous. In addition, there is some conservation of sequences in the 3'-nontranslated region. Sequences that are =70% homologous to the underlined regions of Fig. 5 can be found in the 3'-untranslated region of the rat aldolase B cDNA, ending 20 nucleotides upstream from the polyadenylyIltion signal. These sequences have remained similar during the 6 x 107 years since these species' lineages diverged (32) . This region may possibly represent some feature of control of aldolase B expression or reflect the slower rates of evolutionary change for these genes. This question cannot be resolved at this time.
The complete amino acid sequence of rabbit aldolase A has been known for some time (2) . With the information that has been made available by sequence analysis of these aldolase B clones, some interesting comparisons may be made between the isozymes. Though there are some salient differences, which will be discussed below, the amino acid sequence homology between aldolases A and B is quite high.
There is an overall homology of 68% between human aldolase B and rabbit aldolase A. The greatest homology occurs in the middle region of the sequence, near the active site lysine. Between ids, the homology reaches 75%. There are no significant homologies between the 3'-untranslated regions of the messages of these isozymes. In addition to providing information on the structures of the proteins and their messages, these sequence analysis data allow some conclusions to be drawn concerning the mechanism of catalysis by aldolase. Several amino acid residues have been proposed to take part in substrate binding and catalysis on the basis of enzyme inhibition by covalent modification of rabbit aldolase A (3). A useful test of the accuracy of the proposed schemes would be to see which of these residues are conserved between the different aldolases. The high degree of conservation of the amino acid sequences of the isozymes indicates that the structure of aldolase is under severe constraints. Amino acid residues directly involved in the catalytic process would unlikely be changed as the different isozymes diverged.
Several other amino acid residues besides those around the active site lysine 229 (Fig. 3) are also conserved between aldolases A and B. Arg-55, Lys-146, and Arg-148 have been implicated in binding of the substrate (33, 34) and are all present in the new sequence. Likewise, Tyr-363 is conserved in aldolase B. However, some important differences exist. Lai et al. (3) have proposed that Lys-107, Cys-72 or Cys-338, and His-361 take part in a proton transfer system that is necessary for catalysis. While Lys-107 is found in the human aldolase B sequence, position 72 is now a serine, position 338 is an alanine, and position 361 is a tyrosine. The published rat aldolase sequence corroborates our findings at positions 338 and 361.
The question of whether a cysteine is essential for aldolase activity has long been debated. Though modification of several cysteine residues can be correlated with loss of activity (35) , no one has conclusively shown that this is due to loss of a catalytic moiety. However, Anderson (36) has reported that in sturgeon aldolase A, Cys-338 does not exist and, furthermore, that Cys-72 can be modified by certain agents without loss of enzyme activity. On the basis of these data, Anderson has suggested that cysteine is not a catalytically essential residue, but the observed enzyme inactivation caused by chemical modification of Cys-72 and Cys-338 is due to steric hindrance or changes in the conformation of the aldolase subunits. Our data support this hypothesis because human aldolase B lacks cysteine at both of these sites, although we cannot eliminate the possibility of another cysteine in the enzyme taking part in catalysis.
The involvement of a histidine at position 361 in catalysis stems from substantial evidence indicating that modification of His-361 inhibits the activity of aldolase A (37, 38) . Our data clearly indicates a TAT coding for tyrosine at this position. The fact that this has been found in two independent clones, pHL201 and pHL413, as well as in a rat aldolase B clone (8) , suggests that this is not an artifact of cloning. It may be that the explanation is similar to that suggested above for the cysteine residues; modification of the residue in question lessens enzymatic activity due to alterations of the protein conformation, not because the residue actually takes part in the catalytic process.
These clones can be used to further probe the X library of human genomic DNA, in an attempt to obtain complete genes for the human aldolases. In addition to the gene coding for aldolase B, these probes should be able to hybridize to genes for aldolases A and C as well as any pseudogenes for aldolase that might exist.
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